Amyris Inc Among Today's Top Shorts As Major Indices Fall Following The Fed's Meeting MinutesForbes • 08/19/21
Recent Price Trend in Arvinas, Inc. (ARVN) is Your Friend, Here's WhyZacks Investment Research • 07/29/21
Analysts Estimate Arvinas, Inc. (ARVN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/27/21
All You Need to Know About Arvinas, Inc. (ARVN) Rating Upgrade to BuyZacks Investment Research • 07/27/21
Arvinas, Pfizer Announce $2.4B Licensing Agreement For Protein-Degrader Based Breast Cancer TherapyBenzinga • 07/22/21
Pfizer to pay at least $1 billion to develop, commercialize Arvinas' investigational breast-cancer therapyMarket Watch • 07/22/21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471GlobeNewsWire • 07/22/21
Arvinas Participates in Groundbreaking Ceremony for New Space Within Downtown Crossing Development in New HavenGlobeNewsWire • 06/07/21
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising InvestmentSeeking Alpha • 06/02/21
Arvinas Among Top Shorts Today As Dow, S&P 500, And Nasdaq Climb For Another Consecutive DayForbes • 05/14/21
Arvinas Signs Lease for New Space Within Downtown Crossing Development in New HavenGlobeNewsWire • 05/04/21